lixisenatide AVE0010
LTS12809
Phase 3 small_molecule completed
Quick answer
lixisenatide AVE0010 for Type 2 Diabetes Mellitus is a Phase 3 program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed